Literature DB >> 9730694

Clearance of [125I]-tumor necrosis factor-alpha from the brain into the blood after intracerebroventricular injection in rats.

G Chen1, S Reichlin.   

Abstract

To test the hypothesis that brain to blood clearance is a mechanism by which brain inflammation and damage can increase circulating acute phase cytokines, rate of transfer of [125I]-tumor necrosis factor-alpha ([125I]-TNF) from brain to blood was determined. Acid precipitable [125I]-TNF appeared in peripheral blood within 5 min of intracerebroventricular (i.c.v.) injection and was cleared from brain to blood following first order kinetics at a fractional rate of 0.01123 +/- 0.0030/min, a value virtually identical with a previously determined clearance rate of [125I]-IL-6. Area under blood concentration curve compared with that after intravenous injection shows that 31.6 +/- 5.8% of the intracerebral dose reached peripheral blood in 4 h. Elevated ratios of superior sagittal sinus to aortic blood radioactivity concentration at 1 and 3 h (1.48 +/- 0. 26, p = 0.042; 1.95 +/- 0.39, p = 0.026, respectively) indicate that TNF-alpha drains from brain at least in part via the sagittal sinus. Escherichia coli lipopolysaccharide i.c.v. injection increased the rate of brain efflux of TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730694     DOI: 10.1159/000026346

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  9 in total

Review 1.  Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier.

Authors:  Michelle A Erickson; Kenji Dohi; William A Banks
Journal:  Neuroimmunomodulation       Date:  2012-01-11       Impact factor: 2.492

Review 2.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 3.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

Review 4.  Alcohol, inflammation, and blood-brain barrier function in health and disease across development.

Authors:  A S Vore; T Deak
Journal:  Int Rev Neurobiol       Date:  2021-08-11       Impact factor: 4.280

Review 5.  The blood-brain barrier in neuroimmunology: Tales of separation and assimilation.

Authors:  W A Banks
Journal:  Brain Behav Immun       Date:  2014-08-27       Impact factor: 7.217

6.  Assessing blood granulocyte colony-stimulating factor as a potential biomarker of acute traumatic brain injury in mice and humans.

Authors:  William A Banks; Kenji Dohi; Kim Hansen; Hilaire J Thompson
Journal:  Brain Behav Immun       Date:  2015-10-09       Impact factor: 7.217

Review 7.  The blood-brain barrier as an endocrine tissue.

Authors:  William A Banks
Journal:  Nat Rev Endocrinol       Date:  2019-08       Impact factor: 43.330

8.  Evidence for genetic correlation between human cerebral white matter microstructure and inflammation.

Authors:  Amanda L Rodrigue; Emma Em Knowles; Josephine Mollon; Samuel R Mathias; Marinka Mg Koenis; Juan M Peralta; Ana C Leandro; Peter T Fox; Emma Sprooten; Peter Kochunov; Rene L Olvera; Ravindranath Duggirala; Laura Almasy; Joanne E Curran; John Blangero; David C Glahn
Journal:  Hum Brain Mapp       Date:  2019-06-11       Impact factor: 5.399

Review 9.  The interplay of neurovasculature and adult hippocampal neurogenesis.

Authors:  Thomas A Kim; Lu Chen; Shaoyu Ge
Journal:  Neurosci Lett       Date:  2021-06-17       Impact factor: 3.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.